Catyalyst Pharmaceutical Partners (CPRX) Posts Q3 Loss of 5c/Sh.

November 15, 2011 8:10 AM

Catyalyst Pharmaceutical Partners (NASDAQ: CPRX) reported Q3 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07).

No results found